Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy Read more about Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy
Labcorp to Webcast Its Annual Meeting of Shareholders Read more about Labcorp to Webcast Its Annual Meeting of Shareholders
Invitae Receives Court Approval for Sale to Labcorp Read more about Invitae Receives Court Approval for Sale to Labcorp
Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B Read more about Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B
Labcorp Announces 2024 First Quarter Results Read more about Labcorp Announces 2024 First Quarter Results
Labcorp Announces Winning Bid for Select Assets of Invitae Read more about Labcorp Announces Winning Bid for Select Assets of Invitae
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw Read more about Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw
Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit Read more about Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit
Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs Read more about Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs
